Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Keira, Y.
Right arrow Articles by Nishino, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keira, Y.
Right arrow Articles by Nishino, I.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

J. Biochem, 2003, Vol. 133, No. 5 659-664
© 2003 Japanese Biochemical Society


BIOCHEMISTRY

Localization of Calpain 3 in Human Skeletal Muscle and Its Alteration in Limb-Girdle Muscular Dystrophy 2A Muscle

Yoko Keira1,3, Satoru Noguchi+,1,3, Narihiro Minami2, Yukiko K. Hayashi1 and Ichizo Nishino1,3

1 Department of Neuromuscular Research, National Institute of Neuroscience, and 2 National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center of Neurology and Psychiatry, 4-1-1 Ogawahigashi, Kodaira, Tokyo 187-8502; and 3 Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Corporation, Kawaguchi, Saitama 332-0012

Calpain 3/p94, the skeletal muscle-specific isoform of the calpain large subunit family, is a protein product of the gene responsible for limb-girdle muscular dystrophy type 2A (LGMD2A). Through yeast two-hybrid experiments, calpain 3 has been shown to bind to titin in myofibrils [Sorimachi et al. (1995) J. Biol. Chem. 270, 31158–31162]. However, because of extensive autolysis activity, calpain 3 localization in skeletal muscle has been undefined. In this study, we generated a polyclonal antibody against an N-terminal 98-amino-acid calpain 3 fragment, which is not homologous to the corresponding regions of other conventional calpains. This antibody stained myofibrils with a unique repeated doublet-pattern. Confocal microscopic observation with marker antibodies confirmed that calpain 3 is localized in the N2 region of myofibrils. Furthermore, using this antibody, we examined the localization of calpain 3 in LGMD2A muscles.

+ To whom correspondence should be addressed. Tel: +81-42-341-2711, Fax: +81-42-346-1742, E-mail: noguchi{at}ncnp.go.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Verburg, R. M. Murphy, I. Richard, and G. D. Lamb
Involvement of calpains in Ca2+-induced disruption of excitation-contraction coupling in mammalian skeletal muscle fibers
Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1115 - C1122.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. M. Murphy and G. D. Lamb
Endogenous Calpain-3 Activation Is Primarily Governed by Small Increases in Resting Cytoplasmic [Ca2+] and Is Not Dependent on Stretch
J. Biol. Chem., March 20, 2009; 284(12): 7811 - 7819.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
M. P. Walker, T.K. Rajendra, L. Saieva, J. L. Fuentes, L. Pellizzoni, and A. G. Matera
SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain
Hum. Mol. Genet., November 1, 2008; 17(21): 3399 - 3410.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. Liu, M. C. Liu, and K. K. W. Wang
Calpain in the CNS: From Synaptic Function to Neurotoxicity
Sci. Signal., April 8, 2008; 1(14): re1 - re1.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
M Fanin, L Nardetto, A C Nascimbeni, E Tasca, M Spinazzi, R Padoan, and C Angelini
Correlations between clinical severity, genotype and muscle pathology in limb girdle muscular dystrophy type 2A
J. Med. Genet., October 1, 2007; 44(10): 609 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
R. M. Murphy, C. A. Goodman, M. J. McKenna, J. Bennie, M. Leikis, and G. D. Lamb
Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise
J Appl Physiol, September 1, 2007; 103(3): 926 - 931.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. M. Murphy, E. Verburg, and G. D. Lamb
Ca2+ activation of diffusible and bound pools of {micro}-calpain in rat skeletal muscle
J. Physiol., October 15, 2006; 576(2): 595 - 612.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ono, F. Torii, K. Ojima, N. Doi, K. Yoshioka, Y. Kawabata, D. Labeit, S. Labeit, K. Suzuki, K. Abe, et al.
Suppressed Disassembly of Autolyzing p94/CAPN3 by N2A Connectin/Titin in a Genetic Reporter System
J. Biol. Chem., July 7, 2006; 281(27): 18519 - 18531.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Verburg, T. L. Dutka, and G. D. Lamb
Long-lasting muscle fatigue: partial disruption of excitation-contraction coupling by elevated cytosolic Ca2+ concentration during contractions
Am J Physiol Cell Physiol, April 1, 2006; 290(4): C1199 - C1208.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. A. Huebsch, E. Kudryashova, C. M. Wooley, R. B. Sher, K. L. Seburn, M. J. Spencer, and G. A. Cox
Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain
Hum. Mol. Genet., October 1, 2005; 14(19): 2801 - 2811.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
E. Verburg, R. M. Murphy, D. G. Stephenson, and G. D. Lamb
Disruption of excitation-contraction coupling and titin by endogenous Ca2+-activated proteases in toad muscle fibres
J. Physiol., May 1, 2005; 564(3): 775 - 790.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
I. Kramerova, E. Kudryashova, J.G. Tidball, and M. J. Spencer
Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro
Hum. Mol. Genet., July 1, 2004; 13(13): 1373 - 1388.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.